Objective: Matrix-associated autologous chondrocyte implantation has been used to treat cartilage defects. We developed a biphasic cylindrical osteochondral composite construct for such use, and conducted this study to determine its feasibility for treating osteochondral lesions in human knees. Method: Ten patients with symptomatic osteochondral lesions at femoral condyles were treated by replacing pathological tissue with the construct of DL-poly-lactide-co-glycolide, whose lower body was impregnated with b-tricalcium phosphate and served as osseous phase. The construct had a chamber to load double-minced autologous cartilage, serving as source of chondrocytes. Osteochondral lesion was drill-fashioned a pit of identical dimension as the construct. Chondrocyte-laden construct was press-fit to fill the pit. Postoperative outcome was evaluated using Knee Injury and Osteoarthritis Outcome Score (KOOS) scale up to 24 months. Magnetic resonance image was taken, and sample tissue was collected with second-look arthroscopic needle biopsy at 12 months. Outcome parameters were primarily safety of surgery, and secondarily postoperative change in KOOS and regeneration of hyaline cartilage and cancellous bone. Results: No patient experienced serious adverse events. Postoperative mean KOOS in "symptoms" subscale had not changed significantly from pre-operation until 24 months; whereas those in the other four subscales were significantly higher than pre-operation at 12 and 24 months. Second-look arthroscopy showed completely filled grafted sites, with regenerate cartilaginous surfaces flushed with surrounding native joint surface. Microscopically, regenerated cartilage appeared hyaline. Conclusion: This novel construct for chondrocyte implantation is safe for surgical application in knee. It repairs osteochondral lesions of femoral condyles by successful regeneration of hyaline cartilage.
Introduction
Focal articular cartilage and osteochondral defects are common in working population. Lesions in weight-bearing joints such as knee impair quality of life as much as severe osteoarthritis 1 . Untreated full-thickness cartilage defects in adults heal poorly and can progress to catastrophic arthritis 2 . Conventional surgeries, including debridement, abrasion chondroplasty, and marrow stimulation such as microfracture are successful only in young patients with small lesions 3 . Osteochondral autografting such as mosaicplasty has good clinical results, but its use is restricted to small lesions because of morbidity at larger donor sites 4 . Recent advances in autologous chondrocyte implantation (ACI) have yielded more promising outcomes through successful repair of defects using regenerated cartilage 5 . The clinical results are comparable or superior to conventional surgeries 3 .
ACI continues to evolve around two major issues: ways of obtaining an adequate number of chondrocytes to regenerate cartilage, and secure implantation of cells to defect site 4 . In earlier models of ACI, defect was sealed over with a membrane, and cellsuspension was injected behind the membrane. This process required delicate surgical techniques and bore concerns about uneven cell distribution and cell leakage 6 . In order to overcome these problems, biodegradable scaffolds serving as cell carriers were developed for matrix-associated autologous chondrocyte implantation (MACI). MACI was originally the product name of a type I/III collagen fleece (Verigen, Leverkusen, Germany); the cellseeded fleece was glued onto a prepared chondral defect. The procedure could be performed more easily than ACI and yielded comparable clinical results 7 . Some scaffolds consisting of various biomaterials have been used for MACI 8, 9 . However, firmness of implant attachment has been debated 10, 11 ; inadequate security of implantation may lead to dehiscence of the implant from bone during joint motion. Furthermore, many cartilage lesions such as osteonecrosis and osteochondritis dissecans are associated with pathology of subchondral bone. Any treatment of a surface chondral lesion without support from an intact subchondral bed is likely to fail 12 . One study combined autologous bone grafts and MACI to treat osteochondral lesions 13 , but the surgical procedures were complicated. A more convenient solution could be a pre-fashioned, biphasic osteochondral composite which self-secures to defect site without additional fixation and mends both cartilage and subchondral bone. The clinical success of mosaicplasty with osteochondral grafts supports this approach 14, 15 . Many biphasic osteochondral constructs have been designed recently 16e18 , but few have been used clinically. Previous in vitro studies indicated a need for a large number of chondrocytes to engineer cartilage 19 . Because autologous donor cartilage is extremely scarce, harvested chondrocytes need to be cultureexpanded before being implanted during a second surgery. Recent studies indicated that chondrocytes of lower seeding density on selected biomaterial scaffolds can synthesize good cartilage in vivo without prior monolayer expansion 20, 21 , probably because the cartilage defect environment acts as a "bioactive chamber" with natural settings 22 . An alternative to avoid culture-expansion of cells is the implantation of minced cartilage, which has been proved as an effective intraoperative cell source for cartilage repair 23 . These findings have made graft harvest and implantation possible in a single surgery.
On the basis of these concepts, we developed a novel biodegradable biphasic osteochondral construct for implantation of minced autologous cartilage as the source of chondrocytes to repair cartilage defects 24 . The construct was loaded with "double-minced" autologous cartilage which was processed sequentially by mechanical mincing using a power-driven pulverizer and by chemical mincing using enzymatic dissociation. The minced cartilage-loaded construct was implanted to repair osteochondral lesion in a singlestage, seed-and-implant surgery. The surgical applicability and standardized surgical procedures for this construct had been verified in a porcine model in which regeneration of hyaline cartilage successfully repaired artificially created osteochondral defects in the knee joints 25 . We conducted this human clinical feasibility study to verify the safety of the surgical application of this construct to repair osteochondral lesions on femoral condyles of knee joints. The efficacy of this construct in regenerating cartilage and improving symptoms was also evaluated.
Methods

Biomaterial
The biphasic construct was fabricated with a modified solvent merging/particulate leaching method as previously described 24 .
The product was a cylindrical plug, 8.5 mm wide and 8.5 mm high (Fig. 1) . About one-sixth of height of the cylinder was polylactic-coglycolic acid (PLGA) , and it served as the chondral phase. The remainder was comprised of a PLGA-tricalcium phosphate (TCP) composite, and it served as the osseous phase. A flat chamber, 6.5 mm wide and 1 mm thick, lay between the two phases and served as the reservoir space for processed autograft.
All products were fabricated in a good manufacturing practice (GMP) compliant laboratory, and had passed preclinical evaluations including toxicology tests and animal experiments 24, 26 . Efficacy of the biphasic constructs to regenerate cartilage in knee joint, and applicability of the surgical procedures and instruments, had been testified on a porcine model 8, 21 .
Patient recruitment and baseline evaluation
The protocol for this prospective clinical feasibility study was approved by Institutional Review Board of the corresponding author's hospital, and the national ministry of health with full compliance to national legal regulation on clinical trial, and the Helsinki Declaration. Consecutive patients with symptomatic osteochondral lesions visiting our clinic who fulfilled the following inclusion criteria were invited to participate in the study: (1) age 18e60 years and having a symptomatic osteochondral lesion of the femoral condyle of knee joint, as diagnosed by plain roentgenography and magnetic resonance imaging (MRI); (2) skeletally mature as determined with plain roentgenography, with closure or absence of physeal plate at distal femur and proximal tibia; (3) a lesion whose largest dimension did not exceed 20 mm, as measured with MRI, and (4) a lesion of grades 3 or 4, according to Dipaola's classification with MRI 27 . We excluded patients with unhealed fractures in either lower limb, diffuse degenerative changes in cartilage in the object knee, serologically confirmed rheumatism, metabolic arthropathy such as gouty arthritis, and knee stiffness for any reason with a flexion contracture exceeding 20 and/or maximal flexion less than 130 , and those who were pregnant. During implantation surgery, the lesion was first re-evaluated with arthroscopy. Only lesions of grades 3 or 4 as per Guhl's classification 28 were subjected to implantation; milder lesions were debrided arthroscopically, and patients with these lesions were excluded from the study. A cohort of 12 patients was eligible, 10 of whom were included in the study: six men and four women, with average age of 27.6 years. All 10 lesions (five on lateral condyle and five on medial condyle) were osteochondral, as being depicted by MRI. The MRI findings of these lesions were uniform, featuring well-defined osteochondral area with intermediate signal in all sequences that clearly delineate the pathological tissue from the host bone (Fig. 2) . Three patients had undergone operations in the object knees: one had reconstruction of anterior cruciate ligament with an ipsilateral bone-patellar tendon-bone autograft 2 years earlier, one had arthroscopic debridement for the osteochondral lesion 1 year prior, and one had repair of the osteochondral lesion with an autologous periosteal patch 1 year prior. The latter two lesions failed to regenerate cartilage in the chondral defects.
Every participating patient signed an informed consent before surgery, and an independent study nurse interviewed the patients and assisted them with self-assessment of knee function which was evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire. Patients used a 100 mm visual analog scale (VAS) to indicate pain in the subject knee joints while they sat down and arose from a chair or alternatively squatting.
Surgical procedures and postoperative protocol
All surgeries were performed by a medical team which included the authors. Under spinal anesthesia, the knee joint first underwent routine arthroscopy to confirm site and condition of the lesion. Depending on the lesion site, a lateral or medial minimal parapatellar arthrotomy was made to expose the lesion. An 8-mm diameter circle was marked with a punch, with its edge being placed at junction of the lesion and neighboring native healthy cartilage when the lesion was larger than circular area of the punch, or fully covering the lesion when the lesion was smaller. A maximum of three circles were made in a mosaic fashion to cover large lesions. Cartilage within the circles, if it was of acceptable quality, was excised and retained as part of the autograft. Additional autograft was harvested from non-articulating margin of the affected condyle by curettage. All graft was collected in a special measure container, and a total packed volume of 0.15 cm 3 cartilage was harvested. Holes were drilled into the subchondral cancellous bone using a specially designed drill and guide to form cylindrical pits 8.5 mm in diameter and 8.5 mm deep from articular surface. The collected cartilage graft was immersed immediately in sterile saline and morcelized with a specially designed tissue pulverizer with a sieve to obtain particles smaller than 1,000 mm.
Collagenase (Librase, Roche Diagnostics, Mannheim, Germany) was added to further dissociate the tissue particles at 37 C for 20 min. The dissociated tissue was rinsed three times with 20 ml of saline to remove residual collagenase, resuspended in 0.8 ml saline, and transferred with a syringe to the chamber of the biphasic implant.
At the time of graft implantation, the prepared biphasic constructs were manually press-fit in the cylindrical defects such that surface of the chondral phase appeared flush with the articular surface (Fig. 2) . One lesion required two constructs, another one required three constructs, and the others needed a single construct each to repair the majority of the lesion, if not the entire lesion. The wound was closed in layers. A knee brace was applied that restricted knee motion from 0 to 90 flexion. Patients were instructed to walk partial weight bearing on the operated leg using crutches, immediately after recovery from anesthesia. Patients were discharged on the third postoperative day, and wound healing was confirmed at out-patient clinic 1 week later. A brace was used for 6 weeks postoperatively. Patients were not allowed to participate in vigorous sports activities until 6 months postoperatively.
Follow-up evaluation
KOOS and VAS score were evaluated in follow-up clinics at 6 weeks and 3, 6, 12, and 24 months. Any adverse events (AEs) and serious AEs (as defined by the US Food and Drug Administration 29 ) that caused disability of operated limb or required another hospitalization were recorded. Plain roentgenography, MRI, and second-look arthroscopy were done at 12 months postoperatively. Acquisition of MRI from a 1.5 T machine (GE Sigma EXCITE) included at least fast spin-echo (T2-FSE) and 3-dimensional fat-suppressed gradient-echo (3D-GE-FS) sequences. The repair site was identified during arthroscopy, and a sample of regenerated tissue was collected from the center using a 1-mm diameter biopsy trephine driven perpendicular to surface of the repair to about 10 mm deep. The harvested sample of regenerated osteochondral tissue was formalin-preserved, decalcified overnight in sodium citrate-formic acid solution, and embedded in paraffin. The embedded specimen was then microsectioned for routine hematoxylin-eosin (HE) staining, Alcian blue staining for proteoglycan, and immunohistological staining for collagen type II (Chemicon, Temecula, CA). The regenerated tissue slide was evaluated using microscopy and by the ICRS (International Cartilage Repair Society) Visual Histological Assessment Scale 30 . The regenerated osteochondral tissue was defined as of acceptable quality when none of the scores in the scale, including surface, matrix, cell distribution, cell population viability, The prepared construct was press-fit to the recipient site so that its surface was flush with the articular surface.
subchondral bone, and cartilage mineralization scores, was zero. Regenerated cartilage was defined as being hyaline when the ground substance was homogeneous without fibrous texture as determined with HE staining, was positively stained with Alcian blue, demonstrated a predominance of collagen type II with immunohistological staining, and had round viable cells existing individually or in short columns in lacunae. Cells were considered viable if HE staining revealed a clearly delineated nucleus 31 . Photo images of the lesion sites obtained during arthroscopy from all patients before and 12 months after the repair surgery were inspected in random order by an orthopedic surgeon blinded to source of the images. Each lesion was scored using a previously proposed gross grading scale 31 . MRI of the lesion sites at 12 months postoperatively was interpreted by an independent radiologist, to evaluate quality of the regenerate tissue by the revised MOCART (Magnetic resonance Observation of Cartilage Repair Tissue) scale 32 .
Statistic analysis
Surgical safety was determined by detecting postoperative occurrence of any serious AE or AE, and by calculating the proportion of each of such events at 95% confidence interval (CI), using the Borkowf's method of constructing binomial CIs with near nominal coverage 33 . The KOOS questionnaire includes five subscales, namely pain (Pain), other symptoms (Symptoms), activities of daily living (ADL), sports and recreational activities (Sport/Rec), and quality of life (QoL). For each patient, score of each subscale was analyzed separately. Raw scores in a subscale were summed, normalized, and transformed as instructed in the KOOS manual. The final score of a subscale was a percentage score reversely proportional to severity of the problem, with 100 indicating no problem at all. Mean KOOS and mean VAS score of all 10 patients at each time of follow-up were respectively compared with the pre-operative value using Wilcoxon signed rank test, with P < 0.05 regarded as statistically significant difference for each comparison. Mean gross grading scores of all 10 patients at 12-month follow-up were compared with the pre-operative value in the same way. Statistic calculations were done with SPSS software (version 16.0.1, SPSS Inc., Chicago, IL) on a Microsoft Windows-based computer.
Results
All 10 patients completed the 2-year follow-up. There were no complication such as infection or serious hemarthrosis during postoperative period; all wounds healed well by 1 week after surgery. Minor AEs, including moderate swelling of knee joints and soreness of knee joint during motion, were recorded at 6-week follow-up (Table I ). All of these problems disappeared at 3-month follow-up without treatment. No patient experienced any serious AE during the entire follow-up period.
Postoperative mean KOOS in the Symptoms subscale had not changed significantly from mean pre-operative value until 24 months, when the KOOS became significantly higher than preoperation. For all the other four subscales, postoperative mean KOOS at 12 months and at 24 months were significantly higher than pre-operation. Mean VAS scores at chair rise decreased gradually postoperatively and were significantly lower than the preoperative value after 3 months. Postoperative mean VAS scores at squatting had been insignificantly lower than the pre-operation until 24 months, when the difference became significant (Fig. 3) .
Plain roentgenography at 12 months showed radiopaque trabecule within the original bony pit at grafted site. However, MRI signal from the content within bony pit differed from that from the neighboring native bone, so that the bony graft site was demarcated with a blurred boundary. In seven patients, second-look arthroscopy showed that the grafted sites were completely covered with cartilaginous tissue with a flush smooth surface that integrated well with adjacent native cartilage without a gap. In the other three patients, cartilage regeneration within the lesion was incomplete, and cartilage was intermingled with coarse fibrous tissue and pits exposing the subchondral bone (Figs. 4 and 5) . Mean gross score at 12 months was significantly higher than the pre-operative value (12.9 vs 5.5).
Gross appearance of the biopsy specimens typically demonstrated a tri-layer cylinder with seamless bonding between layers. The opaque white cartilage was approximately 2 w 3 mm thick, followed by a thin, clearer zone that gradually transitioned into cancellous bone tissue. In the brownish bony tissue, residual TCP biomaterial was visible as a chalky substance encapsulated in a clearer matrix. Histological examinations revealed regenerated cartilaginous tissue in the chondral phase without residual biomaterial. The cartilage was hyaline in nature, with viable cells evenly distributed in a mixed columnar-cluster pattern (Fig. 6) . Tissues in all specimens were graded as acceptable quality using ICRS scale, and were all positively stained with Alcian blue and with immunohistological staining for collagen type II.
MRI appearance of the repaired site at 12 months postoperatively (Fig. 7) paralleled arthroscopic and histological findings. During systematic review of the regenerated cartilage with MOCART scale (Table II) , the variables "degree of defect repair/filling of defect", "integration to border zone", and "surface of repair tissue" were compatible with the arthroscopic finding, and the variable "structure of repair tissue" was compatible with the histological finding of biopsy specimen.
Discussion
This study was designed to evaluate the clinical feasibility of repairing osteochondral defects with a novel biphasic biomaterial with a single seed-and-implant surgery.
This biphasic construct has a spongy chondral phase covering a flat chamber, which serves as a reservoir for implanted cells. An essential factor for successful ACI is secure retention of implanted cells at the recipient site, where the chondrocytes deposit chondral matrix and build cartilage. MACI uses a porous scaffold to retain cells, largely by adhesion of cells to inner surface of the construct. The design of a scaffold should be optimized to support cell growth, to allow nutrient transport, and to prevent cell loss 34 . Some scaffolds use sophisticated techniques, such as conjugating RGD (ArgGly-Asp) peptide to the biomaterials, to enhance chondrocyte attachment 35 . The unique design of our construct is expected to hold chondrocytes in the construct. Cells in the reservoir chamber are actually double-minced cartilage fragments instead of free individual chondrocytes. The concept of cartilage regeneration using minced cartilage resembles that of autogenous bone grafting, a common clinical practice in which morcelized cancellous bone is grafted at a fracture site to build callus for bone union. There is an inverse relationship between cartilage fragment size and amount of Table I Proportion of AEs after implantation of chondrocyte-laden biphasic construct as in this series of patients (n ¼ 10) and as calculated at 95% CI using Borkowf's method chondral outgrowth, i.e., the smaller fragment size can yield more cartilage because the highest level of cellular activity is localized at the fragment edge 36 . Therefore the cartilage should be intensively minced to obtain the largest total surface area for optimal growth of repair cartilage. We used a double-mincing system for this purpose. Autologous cartilage was first mechanically minced to tiny fragments by the tissue pulverizer, and was further chemically minced by enzymatic dissociation of the ground substance. These procedures created clusters of chondrocytes entrapped in a loose matrix, and allowed the cells to be slowly released as the matrix broke down, causing the cells to migrate into the spongy chondral phase of the construct after implantation. Contents of matrix such as type II collagen, chondroitin sulfate, and hyaluronan help preserve phenotype of implanted chondrocytes 37, 38 .
Our previous in vivo studies showed that chondrocytes released from degrading cartilage fragments move into PLGA chondral phase instead of entering TCP-containing osseous phase 25, 26 . The basis for this may be from a more active exchange of fluid in the chondral phase with joint motion. When the spongy chondral phase is compressed, the fluid content is squeezed into the joint space. As the compression is released, negative pressure in the chondral phase draws free cells in the reservoir chamber into the spongy space. Another possible reason why chondrocytes stayed away from osseous phase is the hypothetic "material preference" of chondrocytes. A report on an in vitro study with a similar biphasic construct with PLGA/TCP in osseous phase indicated that seeded chondrocytes preferentially stayed in the chondral phase of PLGA 16 .
The in vivo formation of subchondral cancellous bone is considered independent of pre-seeding osteogenic cells to the construct 21, 39 . The porous construct absorbs host marrow, which contains osteogenic stromal cells, and undergoes osteogenesis when exposed to TCP content in the construct 40e42 . TCP has good osteoconductivity when used as a biomaterial implant and may enhance affinity of the implant to the host bone 43, 44 . We observed bone formation in osseous phase of all specimens, with remodeling along the implantehost interface. However, cell-based bioresorption of TCP is a slow process, with possible long-term persistence of this ceramic material 39 . Although PLGA in chondral phase of our constructs dissolved completely, residual TCP content in osseous phase was observed 12 months after implantation.
All 10 lesions on our patients were osteochondral that involved pathology of both cartilage and bone. However, plain X-ray image clearly depicted the lesion in only four patients. MRI is the most widely accepted tool to identify osteochondral lesions in the knee, with high sensibility and specificity 45, 46 . All lesions in our series were clearly demonstrated by MRI by different intralesional signal from host bone in all sequences. The Articular Cartilage Imaging Committee of ICRS has recommended a detailed procedure of imaging for surgically regenerated cartilage 32 . With selective sequences, MRI acquired from standard 1 or 1.5 T scanners can well depict morphology and structure of the regenerated cartilage 47 . This held true with our findings: the MRI appearance of regenerated cartilage paralleled visual findings through arthroscope, and could be a noninvasive alternative to illustrate the outcome of cartilage repair. Very few scales for a systemic review on MRI of regenerated cartilage are found in the literature. We relied primarily on arthroscopic and histological findings to assess the repair tissues, but also used the revised MOCART scale to evaluate MRI appearance of such tissues. A difficulty to use MOCART scale for our osteochondral repair was its original design for cartilage-only repair. The "subchondral lamina" and "subchondral bone" variables in the scale pertain to native bone under the implanted chondral graft. However, both subchondral lamina and subchondral bone were pathological in our patients, and were replaced by the biphasic construct. Although histology of the regenerated tissue showed rebuilt cancellous bone in osseous phase of the construct, the regenerated bone was consistently more hypo-intense than host bone on MRI. In nine patients, subchondral lamina rebuilt on MRI at 12 months postoperatively. The ICRS scale assesses histological quality of regenerated cartilaginous tissue in a systematic and objective way, with six parallel criteria. The "cell distribution" criterion considers that chondrocytes in the middle and lower zone of healthy mature cartilage distribute in a columnar pattern, and the cluster pattern is less favorable 30 . However, the columnar pattern of chondrocyte distribution is derived from endochondral ossification of epiphysis during bone maturation 48 , and may not necessarily rebuild in regenerated cartilage. The cell distribution in our biopsy specimens was all a mixed columnar-cluster pattern. Although cluster pattern has been considered a negative feature associated with degeneration in osteoarthritis tissue, its presence in immature and developing cartilage may indicate remodeling of cartilage tissue during the healing process 49 . The ICRS scale uses HE staining to evaluate the nature of matrix, and does not recommend the use of special staining. We also found HE staining useful in defining the texture of the cells in regenerated cartilaginous tissue. However, we also regard special staining, such as the Alcian blue and immunohistological staining, helpful to characterize chemical contents of the cartilaginous matrix. Beside histological characteristics, mechanical properties of regenerated cartilage are also important for such tissue to bear weight. Although we previously used indentation test to define the viscoelastic nature of regenerated cartilage in an animal model 25 , such test was hardly applicable in the clinical setting. KOOS is validated for several knee disabilities, including focal cartilage lesions 50 . Among the five subscales of KOOS, the QoL subscale is the most disease-specific and best discriminates focal cartilage defects from other knee diseases such as deficiency of anterior cruciate ligament 1 . After the surgery, we observed the largest increase in score in QoL subscale among all subscales. Contrarily, the Symptom subscale concerns primarily with knee motion, which is not usually affected by focal cartilage lesions. Our patients had a mean Symptoms score of 83 pre-operatively, and the score had not increased significantly postoperatively until the follow-up at 24 months.
In conclusion, our preliminary findings indicate that the biphasic cylindrical construct does not bear any serious AE after implantation, therefore is safe for clinical use. The constructs are securely press-fit without additional fixation, and support regeneration of articular cartilage to repair the original chondral defect. Cancellous bone formed in the osseous phase without pre-seeding of cells. This single-stage implantation of double-minced autologous cartilage with the biphasic osteochondral composite presents an alternative to mosaicplasty, without the limitations of insufficient graft resource and donor site morbidity.
